GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us

Article Type
Article
Changed
Fri, 02/01/2019 - 10:36
Display Headline
GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us
Author(s)
Derek P. Chew, MBBS
David J. Moliterno, MD
Article PDF
content_68_1017.pdf
Author and Disclosure Information

Derek P. Chew, MBBS
Department of Cardiovascular Medicine, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Address: David J. Moliterno, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; molited@ccf.org

Dr. Moliterno has indicated that he has received grant or research support from the Centocor, Eli Lilly, and Merck corporations.

Issue
Cleveland Clinic Journal of Medicine - 68(12)
Publications
Cleveland Clinic Journal of Medicine
Topics
Cardiology
Drug Therapy
Vascular
Page Number
1017-1023
Sections
Interpreting Key Trials
Author(s)
Derek P. Chew, MBBS
David J. Moliterno, MD
Author(s)
Derek P. Chew, MBBS
David J. Moliterno, MD
Author and Disclosure Information

Derek P. Chew, MBBS
Department of Cardiovascular Medicine, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Address: David J. Moliterno, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; molited@ccf.org

Dr. Moliterno has indicated that he has received grant or research support from the Centocor, Eli Lilly, and Merck corporations.

Author and Disclosure Information

Derek P. Chew, MBBS
Department of Cardiovascular Medicine, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Address: David J. Moliterno, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; molited@ccf.org

Dr. Moliterno has indicated that he has received grant or research support from the Centocor, Eli Lilly, and Merck corporations.

Article PDF
content_68_1017.pdf
Article PDF
content_68_1017.pdf
Issue
Cleveland Clinic Journal of Medicine - 68(12)
Issue
Cleveland Clinic Journal of Medicine - 68(12)
Page Number
1017-1023
Page Number
1017-1023
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Topics
Cardiology
Drug Therapy
Vascular
Article Type
Article
Display Headline
GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us
Display Headline
GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us
Sections
Interpreting Key Trials
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media
Subscribe to Derek P. Chew, MBBS